Patent. WO2021213287A1 【IF: 0】Patent. WO2021213287A1 2021 Oct 28 CA-4948 purchased from AbMole
Behavioral-transcriptomic landscape of engineered T cells targeting human cancer organoids 【IF: 0】bioRxiv. 2021 May 6;442764 Y-27632 dihydrochloride purchased from AbMole
Patent. CN113499440A 【IF: 0】Patent. CN113499440A 2021 Oct 15 Erastin purchased from AbMole
Patent. CN112852714A 【IF: 0】Patent. CN112852714A 2021 May 28 Y-27632 dihydrochloride purchased from AbMole
Rapamycin's osteogenic effects on bone marrow mesenchymal stem cells through triggering autophagy 【IF: 0】Int J Case Rep Orthop. 2021;3(2):129-134 Rapamycin purchased from AbMole
Patent. WO2021047775A1 【IF: 0】Patent. WO2021047775A1 2021 Mar 18 LY2157299 purchased from AbMole
Patent. CN109652376A 【IF: 0】Patent. CN109652376A 2021-10-15 Y-27632 dihydrochloride purchased from AbMole
Non-coding NFKBIZ 3′ UTR mutations promote cell growth and resistance to targeted therapeutics in diffuse large B-cell lymphoma 【IF: 0】bioRxiv. 2021 May 23;445261 Masitinib purchased from AbMole
Patent. CN113577057A 【IF: 0】Patent. CN113577057A 2021 Nov 02 Selisistat purchased from AbMole
Patent. CN113249482B 【IF: 0】Patent. CN113249482B 2021 Nov 12 GSK1120212 (Trametinib) purchased from AbMole
Patent. US11154543B2 【IF: 0】Patent. US11154543B2 2021 Oct 26 Losmapimod purchased from AbMole
Development and Characterization of an ex vivo Organotypic Non-Small Cell Lung Cancer Model to Study the Effect of Elevated Oxygen Treatment 【IF: 0】University of Bergen. 2021 Jun Y-27632 dihydrochloride purchased from AbMole
Products are for research use only. Not for human use. We do not sell to patients.© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
